Regeneron Pharmaceuticals, Inc.’s filing revealed that its Director BROWN MICHAEL S unloaded Company’s shares for reported $1.6 million on Jun 14 ’24. In the deal valued at $1040.00 per share,1,535 shares were sold. As a result of this transaction, BROWN MICHAEL S now holds 1,382 shares worth roughly $1.47 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, SCHLEIFER LEONARD S sold 16,149 shares, generating $16,406,406 in total proceeds. Upon selling the shares at $1015.94, the Bd. Co-Chair, President & CEO now owns 0 shares.
Before that, SCHLEIFER LEONARD S sold 9,064 shares. Regeneron Pharmaceuticals, Inc. shares valued at $9,203,823 were divested by the Bd. Co-Chair, President & CEO at a price of $1015.43 per share. As a result of the transaction, SCHLEIFER LEONARD S now holds 55,134 shares, worth roughly $58.66 million.
Bernstein initiated its Regeneron Pharmaceuticals, Inc. [REGN] rating to an Outperform in a research note published on March 12, 2024; the price target was $1125. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in mid January from “a Sector perform” to “an Outperform”. Deutsche Bank began covering REGN with “Hold” recommendation on November 09, 2023. Raymond James revised its rating on November 03, 2023. It rated REGN as “an Outperform” which previously was an “a Mkt perform”.
Price Performance Review of REGN
On Monday, Regeneron Pharmaceuticals, Inc. [NASDAQ:REGN] saw its stock jump 1.02% to $1063.89. Over the last five days, the stock has gained 2.64%. Regeneron Pharmaceuticals, Inc. shares have risen nearly 21.13% since the year began. Nevertheless, the stocks have risen 36.43% over the past one year. While a 52-week high of $1059.80 was reached on 06/24/24, a 52-week low of $684.80 was recorded on 01/02/24. SMA at 50 days reached $966.73, while 200 days put it at $904.08. A total of 0.47 million shares were traded, compared to the trading of 0.59 million shares in the previous session.
Levels Of Support And Resistance For REGN Stock
The 24-hour chart illustrates a support level at 1,054.77, which if violated will result in even more drops to 1,045.64. On the upside, there is a resistance level at 1,070.51. A further resistance level may holdings at 1,077.12. The Relative Strength Index (RSI) on the 14-day chart is 77.62, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 28.68, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 5.05%. Stochastics %K at 92.44% indicates the stock is a selling.
#####
#####
#####
#####
